MYC and cancer: Therefore, targeting MYC-regulated miRNAs appears to represent a suitable strategy to interfere with MYC-dependent cancers, although it may be difficult to deliver miRNA mimetics into the tumor tissue of interest without losing their efficacy due to premature degradation.